Alphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity

• Francesca Avogadri,

  Affiliation Swim Across America Laboratory, Immunology Program, Sloan-Kettering Institute, New York, New York, United States of America

  ⨯
• Taha Merghoub,

  Affiliation Swim Across America Laboratory, Immunology Program, Sloan-Kettering Institute, New York, New York, United States of America

  ⨯
• Maureen F. Maughan,

  Affiliation AlphaVax, Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Daniel Hirschhorn-Cymerman,

  Affiliation Swim Across America Laboratory, Immunology Program, Sloan-Kettering Institute, New York, New York, United States of America

  ⨯
• John Morris,

  Affiliation AlphaVax, Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Erika Ritter,

  Affiliation Ludwig Institute for Cancer Research, New York Branch, New York, New York, United States of America

  ⨯
• Robert Olmsted,

  Affiliation AlphaVax, Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Alan N. Houghton,

  Affiliation Swim Across America Laboratory, Immunology Program, Sloan-Kettering Institute, New York, New York, United States of America

  ⨯
• Jedd D. Wolchok

  * E-mail: wolchokj@mskcc.org

  Affiliations Swim Across America Laboratory, Immunology Program, Sloan-Kettering Institute, New York, New York, United States of America, Ludwig Institute for Cancer Research, New York Branch, New York, New York, United States of America

  ⨯